Lois Jovanovic

Learn More
JOHN L. KITZMILLER, MD, MS JENNIFER M. BLOCK, BS RN, CDE FLORENCE M. BROWN, MD PATRICK M. CATALANO, MD DEBORAH L. CONWAY, MD DONALD R. COUSTAN, MD ERICA P. GUNDERSON, RD, PHD WILLIAM H. HERMAN, MD, MPH LISA D. HOFFMAN, MSW, LCSW MARIBETH INTURRISI, RN MS CNS, CDE LOIS B. JOVANOVIC, MD SIRI I. KJOS, MD ROBERT H. KNOPP, MD MARTIN N. MONTORO, MD EDWARD S.(More)
OBJECTIVE Our objective was to formulate a clinical practice guideline for the management of the pregnant woman with diabetes. PARTICIPANTS The Task Force was composed of a chair, selected by the Clinical Guidelines Subcommittee of The Endocrine Society, 5 additional experts, a methodologist, and a medical writer. EVIDENCE This evidence-based guideline(More)
In order for an "artificial pancreas" to become a reality for ambulatory use, a practical closed-loop control strategy must be developed and critically evaluated. In this paper, an improved PID control strategy for blood glucose control is proposed and evaluated in silico using a physiologic model of Hovorka et al. The key features of the proposed control(More)
BACKGROUND Scarce information is available about the variation in the incidence of Type 1 diabetes in the Brazilian population in the last decades. AIM The objective of this study was to assess the long-term trends (1986-2006) in the incidence of Type 1 diabetes in Bauru, São Paulo State, Brazil. SUBJECTS AND METHODS The annual incidence of Type 1(More)
OBJECTIVE To compare long-term glycemic control and safety of using insulin aspart (IAsp) with that of regular human insulin (HI). RESEARCH DESIGN AND METHODS This was a multicenter randomized open-label 6-month study (882 subjects) with a 6-month extension period (714 subjects) that enrolled subjects with type 1 diabetes. Subjects administered IAsp(More)
Abstract The use of continuous subcutaneous insulin infusion (CSII) pumps has been gaining popularity since 1979, when the first research report on insulin pumps was published. Insulin pumps-small medical devices that are programmed to infuse insulin through a catheter placed under the skin-are a replacement for multiple daily injections of insulin. They(More)
BACKGROUND Development of an artificial pancreas based on an automatic closed-loop algorithm that uses a subcutaneous insulin pump and continuous glucose sensor is a goal for biomedical engineering research. However, closing the loop for the artificial pancreas still presents many challenges, including model identification and design of a control algorithm(More)
BACKGROUND Type 1 diabetes mellitus (T1DM) is characterized by the destruction of pancreatic beta cells, resulting in the inability to produce sufficient insulin to maintain normoglycemia. As a result, people with T1DM depend on exogenous insulin that is given either by multiple daily injections or by an insulin pump to control their blood glucose. A(More)